3rd Circ. Finds No Reason To Disturb AbbVie Privilege Ruling

By Matthew Perlman · March 11, 2024, 10:06 PM EDT

The Third Circuit has found that AbbVie was unable to show that a Pennsylvania federal court went against precedent or made an error when ordering the drugmaker to turn over attorney...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

In re: Abbott Laboratories, et al

Case Number

Court

Appellate - 3rd Circuit

Nature of Suit

original proceeding

Date Filed

August 04, 2023

Recent Articles By Matthew

May 16, 2024
Gilead, Teva Want 17 HIV Drug Antitrust Appeals Consolidated
May 13, 2024
2nd Circ. Affirms Dismissal Of Bystolic Antitrust Suit
May 07, 2024
MultiPlan, Insurance Cos. Accused Of Algorithmic Collusion
May 06, 2024
Biotech Co. Wants To Appeal Red Cross Antitrust Immunity
May 02, 2024
Lawmaker Wants Antitrust Probe Of Health Insurance Data Co.
April 18, 2024
EU Antitrust Chief Says Merger Tool Not A 'Power Grab'
April 04, 2024
Novo Holdings, Catalent Reset Review Clock On $16.5B Deal
March 29, 2024
Home Depot Asks High Court To Block $2.67B BCBS Deal
March 26, 2024
FTC Urges Court To Pause Novant's NC Hospital Deal
March 25, 2024
3rd Circ. Won't Rethink AbbVie Privilege Ruling